Ask the Doc" October 2nd - Partnerships in Developing New JM Treatments

In October, Cure JM had two speakers give an update about drug discovery in juvenile myositis. Joni L. Rutter, Ph.D., Director, National Center for Advancing Translational Sciences, National Institutes of Health, updated families about the process of drug discovery and development and how partnerships like Cure JM’s NCATS partnership accelerate new treatments for juvenile myositis. Eric Hoffman, Ph.D., President and CEO, of ReveraGen Pharmaceutical, brought families into the inner circle of understanding how new drugs move through the process and the role that Cure JM, parents, patients, and grandparents play in this process.
Introduction by Jim started 00:17
Dr. Rutter presentation begins 04:50
Q&A with Dr. Rutter started 24:34
Jim Introduces Dr. Hoffman: 30:16
Dr. Hoffman presentation begins 31:31
Q&A following Dr. Hoffman started: 49:38